Posted on Tuesday, December 11, 2012 at 11:02 am CST

TraceGains is hosting a webinar entitled, “Creating an ‘Approved Supplier Program’ as a Prerequisite for a Successful HACCP Program,” on December 12, 2012 from 12:30 pm – 1:30 pm EST. Link to register: www3.gotomeeting.com/register/503607246. The webinar will look at how confident company executives should be when justifying the control of a hazard through an approved supplier program and the percentage of recalls is traced to supplier issues.
Source: TraceGains Inc.
Posted on Tuesday, December 11, 2012 at 11:24 am CST
Christmas discounts are sometimes even more significant than those on Black Friday or Cyber Monday when it comes to electronics. For Christmas, both Amazon and Barnes & Noble have slashed Kindle and Nook prices.
Source: John Colston
Posted on Tuesday, December 11, 2012 at 9:25 am CST

Small businesses are more dependent on their customers and their good reputation than larger companies are. They are also more vulnerable to identity thieves if their owners are not vigilant. It is vitally important to protect the information of customers, clients, and others who rely on a company’s diligence and discretion to keep it safe. An identity theft protection company is an effective method of keeping computer and hard-copy information as safe as possible. Firms that offer this protection receive a fee each month for keeping close watch on the activities of the business and ascertaining that no fraudulent goings-on occur. These companies can also monitor the credit report of the small business so they are able to notify the owner immediately of any unauthorized doings.
Source: Legal-Yogi
Posted on Tuesday, December 11, 2012 at 10:00 am CST

Dermatitis - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dermatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dermatitis.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 9:00 am CST

H1N1 Infection - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for H1N1 Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H1N1 Infection.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 9:15 am CST

Musculoskeletal Pain - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Musculoskeletal Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Musculoskeletal Pain.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 9:30 am CST

Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Keratoconjunctivitis sicca (Dry Eye), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Keratoconjunctivitis sicca (Dry Eye).
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 10:15 am CST

Diabetic Retinopathy - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Retinopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Retinopathy.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 10:00 am CST

Cirrhosis - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cirrhosis.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 9:15 am CST

Overactive Bladder - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Overactive Bladder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Overactive Bladder.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 9:30 am CST

Neutropenia - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Neutropenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neutropenia.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 10:15 am CST

Amyloidosis - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Amyloidosis.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 10:00 am CST

Ocular Hypertension - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Ocular Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ocular Hypertension.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 10:00 am CST

Cachexia - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cachexia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cachexia.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 10:15 am CST

Cough - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cough, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cough.
Source: Reportstack
Posted on Tuesday, December 11, 2012 at 11:21 am CST
Nasal polyps are not medically dangerous, but they are uncomfortable and painful. They can affect breathing and sometimes give severe headache. Medical or surgical treatment does not prevent the recurrence of polyps. Nasal Polyps Treatment Miracle provides some natural treatments that help sufferers to relieve symptoms and also to reduce polyps forever.
Source: John Colston
Posted on Tuesday, December 11, 2012 at 9:55 am CST
Author Eri Nelson is a very hands on writer who carries her unparalleled differences of her craft onto the DHC, Dearhart Clan Series. Being an Indie Author has allowed Eri to travel the broader unhindered aspects to writing freedoms. She never hides or dives from the issues of typos or oops that may appear. In fact, she aspires to rise above them and develop a darkly enriched primal paranormal fantasy that will entice you as well as influence your new flavor in reading.
Source: Piece of Cake PR
Posted on Tuesday, December 11, 2012 at 3:18 pm CST
EZ Corporate Clothing, based in Long Island, knows firsthand the kind of tragic and devastating effects that Hurricane Sandy had on the region when it swept through, leaving destruction and havoc in its path. Thankfully, the quick efforts and donations made in the aftermath of the storm were able to offer an immediate impact for rescue workers on the scene.
Source: EZ Corporate Clothing
Posted on Tuesday, December 11, 2012 at 2:57 pm CST

As any restaurant owner can attest, it doesn’t matter how good the food is or how chic the ambience; if customers aren’t steadily streaming through the seats, success is impossible. Thanks to current technology and social media trends, it’s easier than ever for a restaurant to set itself apart from the competition and build a loyal and engaged customer base. But as society veers toward wide-scale adoption of mobile, restaurants need to stay on-trend and be accessible to their customers at all times. A mobile app is the perfect way to do just that.
Source: Infinite Monkeys LLC
Posted on Tuesday, December 11, 2012 at 1:00 pm CST

Global Markets Direct's, 'Birch Pollen Allergy - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Birch Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Birch Pollen Allergy. Birch Pollen Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, December 11, 2012 at 12:08 pm CST

Global Markets Direct's, 'Gaucher's Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Gaucher's Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gaucher's Disease. Gaucher's Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, December 11, 2012 at 2:58 pm CST

Global Markets Direct's, 'Avitaminosis (Hypovitaminosis) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Avitaminosis (Hypovitaminosis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Avitaminosis (Hypovitaminosis). Avitaminosis (Hypovitaminosis) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, December 11, 2012 at 2:11 pm CST

Global Market Direct's pharmaceuticals report, "Axxam SpA - Product Pipeline Review - 2012" provides data on the Axxam SpA's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Tuesday, December 11, 2012 at 2:01 pm CST

Global Markets Direct's, 'Rhino-Conjunctivitis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Rhino-Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rhino-Conjunctivitis. Rhino-Conjunctivitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Tuesday, December 11, 2012 at 12:50 pm CST

While consumer appliances saw volume growth for most years of the review period, overall review period growth was constrained by a marked decline in sales in 2009. While Saudi Arabia did not enter recession in this year, high inflation and the global economic downturn resulted in strong economic uncertainty, with many consumers postponing purchases of consumer appliances as a result. Growth was however resumed in 2010 and strengthened further in 2011 as consumers' economic confidence rose once...
Source: Fast Market Research